106 related articles for article (PubMed ID: 25524880)
21. Identification of compounds that selectively target highly chemotherapy refractory neuroblastoma cancer stem cells.
Díaz-Carballo D; Acikelli AH; Bardenheuer W; Gustmann S; Malak S; Stoll R; Kedziorski T; Nazif MA; Jastrow H; Wennemuth G; Dammann P; Feigel M; Strumberg D
Int J Clin Pharmacol Ther; 2014 Sep; 52(9):787-801. PubMed ID: 24902844
[TBL] [Abstract][Full Text] [Related]
22. Aldehyde dehydrogenase activity in cancer stem cells from canine mammary carcinoma cell lines.
Michishita M; Akiyoshi R; Suemizu H; Nakagawa T; Sasaki N; Takemitsu H; Arai T; Takahashi K
Vet J; 2012 Aug; 193(2):508-13. PubMed ID: 22326935
[TBL] [Abstract][Full Text] [Related]
23. The oncolytic herpes simplex virus vector G47∆ effectively targets breast cancer stem cells.
Zeng W; Hu P; Wu J; Wang J; Li J; Lei L; Liu R
Oncol Rep; 2013 Mar; 29(3):1108-14. PubMed ID: 23292314
[TBL] [Abstract][Full Text] [Related]
24. High aldehyde dehydrogenase activity enhances stem cell features in breast cancer cells by activating hypoxia-inducible factor-2α.
Kim RJ; Park JR; Roh KJ; Choi AR; Kim SR; Kim PH; Yu JH; Lee JW; Ahn SH; Gong G; Hwang JW; Kang KS; Kong G; Sheen YY; Nam JS
Cancer Lett; 2013 Jun; 333(1):18-31. PubMed ID: 23174107
[TBL] [Abstract][Full Text] [Related]
25. Profiling of Aldehyde Dehydrogenase Isoforms in
Tsochantaridis I; Voulgaridou GP; Giatromanolaki A; Koukourakis MI; Panayiotidis MI; Pappa A
Anticancer Res; 2021 Nov; 41(11):5481-5488. PubMed ID: 34732418
[TBL] [Abstract][Full Text] [Related]
26. Preclinical evaluation of a new liposomal formulation of cisplatin, lipoplatin, to treat cisplatin-resistant cervical cancer.
Casagrande N; De Paoli M; Celegato M; Borghese C; Mongiat M; Colombatti A; Aldinucci D
Gynecol Oncol; 2013 Dec; 131(3):744-52. PubMed ID: 24029417
[TBL] [Abstract][Full Text] [Related]
27. TLX activates MMP-2, promotes self-renewal of tumor spheres in neuroblastoma and correlates with poor patient survival.
Chavali PL; Saini RK; Zhai Q; Vizlin-Hodzic D; Venkatabalasubramanian S; Hayashi A; Johansson E; Zeng ZJ; Mohlin S; Påhlman S; Hansford L; Kaplan DR; Funa K
Cell Death Dis; 2014 Oct; 5(10):e1502. PubMed ID: 25356871
[TBL] [Abstract][Full Text] [Related]
28. Silencing oncogene expression in cervical cancer stem-like cells inhibits their cell growth and self-renewal ability.
Gu W; Yeo E; McMillan N; Yu C
Cancer Gene Ther; 2011 Dec; 18(12):897-905. PubMed ID: 21904396
[TBL] [Abstract][Full Text] [Related]
29. ALDH1A1 in patient-derived bladder cancer spheroids activates retinoic acid signaling leading to TUBB3 overexpression and tumor progression.
Namekawa T; Ikeda K; Horie-Inoue K; Suzuki T; Okamoto K; Ichikawa T; Yano A; Kawakami S; Inoue S
Int J Cancer; 2020 Feb; 146(4):1099-1113. PubMed ID: 31187490
[TBL] [Abstract][Full Text] [Related]
30. Induced differentiation inhibits sphere formation in neuroblastoma.
Craig BT; Rellinger EJ; Alvarez AL; Dusek HL; Qiao J; Chung DH
Biochem Biophys Res Commun; 2016 Aug; 477(2):255-9. PubMed ID: 27297102
[TBL] [Abstract][Full Text] [Related]
31. NFκB Promotes Ovarian Tumorigenesis via Classical Pathways That Support Proliferative Cancer Cells and Alternative Pathways That Support ALDH
House CD; Jordan E; Hernandez L; Ozaki M; James JM; Kim M; Kruhlak MJ; Batchelor E; Elloumi F; Cam MC; Annunziata CM
Cancer Res; 2017 Dec; 77(24):6927-6940. PubMed ID: 29074539
[TBL] [Abstract][Full Text] [Related]
32. The impact of inflammatory lipid mediators on colon cancer-initiating cells.
Bellamkonda K; Sime W; Sjölander A
Mol Carcinog; 2015 Nov; 54(11):1315-27. PubMed ID: 25154976
[TBL] [Abstract][Full Text] [Related]
33. Aldehyde dehydrogenases and cancer stem cells.
Xu X; Chai S; Wang P; Zhang C; Yang Y; Yang Y; Wang K
Cancer Lett; 2015 Dec; 369(1):50-7. PubMed ID: 26319899
[TBL] [Abstract][Full Text] [Related]
34. Tumor endothelial cells with high aldehyde dehydrogenase activity show drug resistance.
Hida K; Maishi N; Akiyama K; Ohmura-Kakutani H; Torii C; Ohga N; Osawa T; Kikuchi H; Morimoto H; Morimoto M; Shindoh M; Shinohara N; Hida Y
Cancer Sci; 2017 Nov; 108(11):2195-2203. PubMed ID: 28851003
[TBL] [Abstract][Full Text] [Related]
35. Chemoresistance acquisition induces a global shift of expression of aniogenesis-associated genes and increased pro-angogenic activity in neuroblastoma cells.
Michaelis M; Klassert D; Barth S; Suhan T; Breitling R; Mayer B; Hinsch N; Doerr HW; Cinatl J; Cinatl J
Mol Cancer; 2009 Sep; 8():80. PubMed ID: 19788758
[TBL] [Abstract][Full Text] [Related]
36. Single-Cell-Derived Tumor-Sphere Formation and Drug-Resistance Assay Using an Integrated Microfluidics.
Pang L; Ding J; Ge Y; Fan J; Fan SK
Anal Chem; 2019 Jul; 91(13):8318-8325. PubMed ID: 31148455
[TBL] [Abstract][Full Text] [Related]
37. Use of retinoic acid/aldehyde dehydrogenase pathway as potential targeted therapy against cancer stem cells.
Moreb JS; Ucar-Bilyeu DA; Khan A
Cancer Chemother Pharmacol; 2017 Feb; 79(2):295-301. PubMed ID: 27942929
[TBL] [Abstract][Full Text] [Related]
38. Acquired resistance of leukemic cells to AraC is associated with the upregulation of aldehyde dehydrogenase 1 family member A2.
Kawasoe M; Yamamoto Y; Okawa K; Funato T; Takeda M; Hara T; Tsurumi H; Moriwaki H; Arioka Y; Takemura M; Matsunami H; Markey SP; Saito K
Exp Hematol; 2013 Jul; 41(7):597-603.e2. PubMed ID: 23507523
[TBL] [Abstract][Full Text] [Related]
39. Revealed: The spy who regulates neuroblastoma stem cells.
Vora P; Venugopal C; Singh SK
Oncotarget; 2014 Nov; 5(22):11014-6. PubMed ID: 25483101
[TBL] [Abstract][Full Text] [Related]
40. Chemoresistance, cancer stem cells, and miRNA influences: the case for neuroblastoma.
Buhagiar A; Ayers D
Anal Cell Pathol (Amst); 2015; 2015():150634. PubMed ID: 26258008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
